telma 20

About

Telma 20, containing Telmisartan, is an angiotensin II receptor blocker (ARB) primarily used in the management of essential hypertension. It works by selectively blocking the binding of angiotensin II to the AT1 receptor in various tissues, including vascular smooth muscle. This action prevents the vasoconstrictive and aldosterone-secreting effects of angiotensin II, leading to a reduction in systemic vascular resistance and blood pressure. Telmisartan is known for its long duration of action, allowing for once-daily dosing, which contributes to improved patient adherence. Beyond its antihypertensive effects, Telmisartan has demonstrated benefits in reducing the risk of cardiovascular morbidity and mortality in patients at high risk, such as those with a history of coronary artery disease, stroke, peripheral arterial disease, or diabetes with end-organ damage. Its renoprotective properties are also noted, particularly in patients with hypertension and type 2 diabetes.

Uses

• Treatment of essential hypertension.
• Reduction of cardiovascular risk in high-risk patients.
• Management of diabetic nephropathy (off-label).
• Adjunctive therapy in heart failure (off-label).

Directions For Use

Take one tablet orally once daily, with or without food, as directed by your physician.

Benefits

• Effective and sustained blood pressure control.
• Reduces the risk of major cardiovascular events.
• Provides renoprotective benefits in certain conditions.
• Convenient once-daily dosing regimen.
• Generally well-tolerated with a low incidence of cough.
• May improve endothelial function.

Side Effects

• Dizziness
• Lightheadedness
• Fatigue
• Headache
• Back pain
• Diarrhea
• Nausea
• Abdominal pain
• Hyperkalemia
• Angioedema (rare)
• Renal dysfunction
• Orthostatic hypotension

Safety Measures

• Alcohol - Alcohol may enhance the blood pressure-lowering effect of Telma 20, potentially leading to increased dizziness or lightheadedness. It is advisable to limit alcohol intake.
• Pregnancy - Telma 20 is contraindicated during pregnancy, especially in the second and third trimesters, due to the risk of fetal harm and death.
• Breastfeeding - Telma 20 is not recommended during breastfeeding as it may pass into breast milk and potentially harm the infant. Consult your doctor.
• Liver - Use with caution in patients with severe hepatic impairment. Dose adjustment may be necessary as Telmisartan is primarily eliminated via bile.
• Kidney - Use with caution in patients with renal impairment. Regular monitoring of kidney function and serum potassium levels is recommended.
• Lung - Telma 20 is generally safe for use in patients with lung conditions, as it does not typically cause respiratory side effects like cough associated with ACE inhibitors.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.